Publication Date:
2021
abstract:
Inhibiting the main protease 3CLpro is the most common strategy in the search for antiviral drugs to fight the infection from SARS-CoV-2. We report that the natural compound eugenol is able to hamper in vitro the enzymatic activity of 3CLpro, the SARS-CoV-2 main protease, with an inhibition constant in the sub-micromolar range (K = 0.81 µM). Two phenylpropene analogs were also tested: the same effect was observed for estragole with a lower potency (K = 4.1 µM), whereas anethole was less active. The binding efficiency index of these compounds is remarkably favorable due also to their small molecular mass (MW < 165 Da). We envision that nanomolar inhibition of 3CLpro is widely accessible within the chemical space of simple natural compounds.
Iris type:
01.01 Articolo in rivista
Keywords:
Antivirals; Drug selection; Enzyme inhibitors; Eugenol; Main protease; Molecular modeling; SARS-CoV-2; Spectroscopy
List of contributors:
Rizzuti, Bruno
Published in: